Figure 2From: The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials Effects of insulin sensitizing drugs versus placebo or no treatment on fasting lipids levels in patients with HIV-associated lipodystrophy syndrome.Back to article page